Swahili
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Effects of Alkaline Phosphatase on Renal Function in Septic Patients

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
Kiungo kimehifadhiwa kwenye clipboard
HaliImekamilika
Wadhamini
Radboud University

Maneno muhimu

Kikemikali

Septic shock is the most common cause of death in patients requiring intensive care. The kidney is one of the first organs to fail, stressing the importance to search for clinical interventions that may protect the kidneys during sepsis.
Alkaline phosphatase functions as a host defence molecule and is present in many cells and organs (e.g. intestine, placenta, liver, kidney and bone). Alkaline phosphatase has a dual mode of action. First, it binds to and, subsequently, dephosphorylates lipopolysaccharide (LPS). Second, the enzymatic reaction product monophosphoryl-LPS is a non-toxic substance for mammals which acts as a partial antagonist on the LPS receptor complex. In several animal studies, administration of alkaline phosphatase attenuates the inflammatory response and reduces mortality.
It is unknown whether these results can be extrapolated to septic patients . We studied the effects of alkaline phosphatse administration on kidney damage and function in patients with severe sepsis or septic shock.

Tarehe

Imethibitishwa Mwisho: 02/28/2006
Iliyowasilishwa Kwanza: 04/03/2007
Uandikishaji uliokadiriwa Uliwasilishwa: 04/04/2007
Iliyotumwa Kwanza: 04/05/2007
Sasisho la Mwisho Liliwasilishwa: 04/04/2007
Sasisho la Mwisho Lilichapishwa: 04/05/2007
Tarehe halisi ya kuanza kwa masomo: 10/31/2004
Tarehe ya Kukamilisha Utafiti: 02/28/2006

Hali au ugonjwa

Severe
Septic
Shock

Uingiliaji / matibabu

Drug: bolus injection, followed by a continuous infusion ( 24 h) (Alkaline phosphatase)

Awamu

Awamu 2

Vigezo vya Kustahiki

Zama zinazostahiki Kujifunza 18 Years Kwa 18 Years
Jinsia Inastahiki KujifunzaAll
Hupokea Wajitolea wa AfyaNdio
Vigezo

Inclusion Criteria:

- Written informed consent

- Proven or suspected Gram-negative bacterial infection

- Two out of four Systemic Inflammatory Response Syndrome (SIRS) criteria existing for less than 24 h

- Acute onset of end-organ dysfunction in the preceding 12 h

Exclusion Criteria:

- Prior therapy with alkaline phosphatase

- Known allergy for cow milk

- Probable death within 24 h

- Chronic renal failure requiring hemodialysis or peritoneal dialysis

- Acute pancreatitis with no established source of infection

- HIV seropositive

- Pregnant or lactating

- Confirmed Gram-positive or fungal sepsis

- Treatment with immunosuppressants including high doses of glucocorticosteroids

Matokeo

Hatua za Matokeo ya Msingi

1. Biomarkers of kidney damage [undefined]

2. kidney function [undefined]

3. markers of inflammation [undefined]

Jiunge na ukurasa
wetu wa facebook

Hifadhidata kamili ya mimea ya dawa inayoungwa mkono na sayansi

  • Inafanya kazi katika lugha 55
  • Uponyaji wa mitishamba unaungwa mkono na sayansi
  • Kutambua mimea kwa picha
  • Ramani ya GPS inayoshirikiana
  • Soma machapisho ya kisayansi yanayohusiana na utafutaji wako
  • Tafuta mimea ya dawa na athari zao
  • Panga maslahi yako na fanya tarehe ya utafiti wa habari, majaribio ya kliniki na ruhusu

Andika dalili au ugonjwa na usome juu ya mimea ambayo inaweza kusaidia, chapa mimea na uone magonjwa na dalili ambazo hutumiwa dhidi yake.
* Habari zote zinategemea utafiti wa kisayansi uliochapishwa

Google Play badgeApp Store badge